1 / 26

EVALUATION OF RA & PA PATIENTS

EVALUATION OF RA & PA PATIENTS. YEAR 2005. GENERAL DEMOGRAPHICS GENDER. PATIENTS’ AGE GROUPS. DURATION OF DISEASE AGE. DIFFERENCE OF MS AT POSTTREATMENT. DIFFERENCE OF VAS (PAIN) AT POSTTREATMENT. DIFFERENCE OF OWB AT POSTTREATMENT. DIFFERENCE OF MHAQ AT POSTTREATMENT.

dorian-chan
Télécharger la présentation

EVALUATION OF RA & PA PATIENTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EVALUATION OF RA & PA PATIENTS YEAR 2005

  2. GENERAL DEMOGRAPHICSGENDER

  3. PATIENTS’ AGE GROUPS

  4. DURATION OF DISEASE AGE

  5. DIFFERENCE OF MS AT POSTTREATMENT

  6. DIFFERENCE OF VAS (PAIN)AT POSTTREATMENT

  7. DIFFERENCE OF OWB AT POSTTREATMENT

  8. DIFFERENCE OF MHAQ AT POSTTREATMENT

  9. DIFFERENCE OF PaGADA AT POSTTREATMENT

  10. DIFFERENCE OF TJ AT POSTTREATMENT

  11. DIFFERENCE OF SwJ AT POSTTREATMENT

  12. DIFFERENCE OF PGADA AT POSTTREATMENT

  13. DIFFERENCE OF DAS 28AT POSTTREATMENT

  14. ANALGESIC USAGE AT PRETREATMENT

  15. DIFFERENCE OF “A” USAGE AT POSTTREATMENT

  16. NSAID USAGE AT PRETREATMENT

  17. DIFFERENCE OF NSAID USAGE AT POSTTREATMENT

  18. STEROID USAGE AT PRETREATMENT

  19. DIFFERENCE OF “STR” USAGE AT POSTTREATMENT

  20. USAGE OF OTHER DRUGS AT PRETREATMENT

  21. DIFFERENCE OF OTHER DRUGS AT POSTTREATMENT

  22. MOSTLY SEEN SECONDARY DISEASES

  23. DAILY POLICLINIC CASES

  24. PATIENTS WHO WERE REFERRED TO HOSPITAL

  25. THANK YOU FOR YOUR ATTENTION

More Related